Access the latest company updates, press releases industry news and events from Deerland Probiotics & Enzymes.

Get Ready for Gift of Hope’s 8th Annual Charity Golf Classic & Auction

With the world reopening, Deerland is thrilled to once again sponsor Gift of Hope, Inc.’s Charity Golf Classic & Auction. This year will mark the eighth annual edition of this fantastic event, which offers an opportunity to give back to a wonderful organization and network with other leaders in the dietary supplement industry and beyond. This opportunity for community building and camaraderie is especially welcome ...
Read More

Deerland Probiotics & Enzymes Expands Branded Probiotic Offering with the Launch of MuniSpore™ Bacillus clausii

Deerland Probiotics & Enzymes, a global supplier of science-backed solutions for microbiome health, has announced the expansion of its branded probiotic spore portfolio with the launch of its newest branded ingredient supporting immune health, MuniSpore™, a science-backed strain of the probiotic Bacillus clausii. MuniSpore is the probiotic strain Bacillus clausii CSI08, a soil-based microorganism. The beneficial effects of the probiotic B. clausii have been attributed ...
Read More

Deerland Probiotics & Enzymes’ Probiotic DE111® First Bacillus subtilis to Attain Notified Food-Health Relationship Claims in Australia and New Zealand

Deerland Probiotics & Enzymes, a global supplier of science-backed solutions for microbiome health, is pleased to announce that its probiotic Bacillus subtilis DE111® has attained a list of published health claims in relationship to its inclusion as a food ingredient under the Food Standards Australia New Zealand (FSANZ) Code. Companies seeking to make a general level health claim for a food ingredient in Australia and ...
Read More

New Study: Probiotic Bacillus subtilis DE111® Shown to Support Immune Health

Deerland Probiotics & Enzymes has announced the publication of a new clinical study examining the immune support effects of Bacillus subtilis DE111®. The study, “Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus subtilis DE111” published in the International Journal of Molecular Sciences, is an IRB-approved, randomized, double-blind, placebo-controlled study involving 44 healthy adults (aged 20 to 62). Participants consumed either B. subtilis ...
Read More

Deerland Probiotics & Enzymes Launches New Company Tagline – “Motivated by science, measured by wellness.”

Deerland Probiotics & Enzymes is pleased to unveil the company’s new global brand tagline-- “Motivated by science, measured by wellness.” The tagline is intended to better align Deerland’s brand identity with its vision “for all people of all cultures to benefit from its enzyme, probiotic and prebiotic health products”, along with its mission “to measurably improve the quality of people’s lives by creating innovative, scientifically ...
Read More

Deerland Probiotics & Enzymes Hires New Business Development Manager for the Southern US Region

Deerland Probiotics and Enzymes, a global supplier of science-backed solutions for microbiome health, has announced the hiring of Arthur Radcliffe as the company’s business development manager responsible for the southern United States. Radcliffe brings more than 25 years of industry experience with Lonza-Capsugel, holding various expanded positions in sales and marketing, most recently as business development manager in the midwest & southeast regions. Operating from ...
Read More

Subscribe to Digestible

An educational enzyme and probiotic resource
Sign Up